200,000+ products from a single source!
sales@angenechem.com
1436-43-7 | Quinoline-2-carbonitrile
CAS No: 1436-43-7 Catalog No: AG003U3M MDL No:MFCD00134341
Product Description
Catalog Number:
AG003U3M
Chemical Name:
Quinoline-2-carbonitrile
CAS Number:
1436-43-7
Molecular Formula:
C10H6N2
Molecular Weight:
154.1680
MDL Number:
MFCD00134341
IUPAC Name:
quinoline-2-carbonitrile
InChI:
InChI=1S/C10H6N2/c11-7-9-6-5-8-3-1-2-4-10(8)12-9/h1-6H
InChI Key:
WDXARTMCIRVMAE-UHFFFAOYSA-N
SMILES:
N#Cc1ccc2c(n1)cccc2
EC Number:
215-865-1
Properties
Complexity:
203
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
154.053g/mol
Formal Charge:
0
Heavy Atom Count:
12
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
154.172g/mol
Monoisotopic Mass:
154.053g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
36.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.6
Literature
| Title | Journal |
|---|---|
| Structure-activity relationships of cyanoquinolines with corrector-potentiator activity in ΔF508 cystic fibrosis transmembrane conductance regulator protein. | Journal of medicinal chemistry 20120209 |
| Cyanoquinolines with independent corrector and potentiator activities restore ΔPhe508-cystic fibrosis transmembrane conductance regulator chloride channel function in cystic fibrosis. | Molecular pharmacology 20111001 |
| 2-Cyano-quinolin-1-ium hydrogen sulfate. | Acta crystallographica. Section E, Structure reports online 20101101 |
| 2-Cyano-quinolin-1-ium nitrate. | Acta crystallographica. Section E, Structure reports online 20101101 |
| Quinoline-2-carbonitrile-fumaric acid (1/0.5). | Acta crystallographica. Section E, Structure reports online 20100901 |
| Quinoline-2-carbonitrile. | Acta crystallographica. Section E, Structure reports online 20100901 |
| 3D-QSAR study of c-Src kinase inhibitors based on docking. | Journal of molecular modeling 20100201 |
| Preparation of heteroaryloxetanes and heteroarylazetidines by use of a Minisci reaction. | The Journal of organic chemistry 20090821 |
| Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways. | Purinergic signalling 20090301 |
| Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. | Bioorganic & medicinal chemistry letters 20090101 |
| Enzyme kinetics and binding studies on inhibitors of MEK protein kinase. | Biochemistry 20080429 |
| 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases. | Bioorganic & medicinal chemistry 20050801 |
| Identification of 4-anilino-3-quinolinecarbonitrile inhibitors of mitogen-activated protein/extracellular signal-regulated kinase 1 kinase. | Molecular cancer therapeutics 20040601 |
| Cleavage of carbon-carbon bonds in aromatic nitriles using nickel(0). | Journal of the American Chemical Society 20020814 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.